Pierre M Bet
Overview
Explore the profile of Pierre M Bet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanrath M, Banken E, van den Wildenberg S, van de Kerkhof D, Moes D, Boisdron-Celle M, et al.
Cancer Chemother Pharmacol
. 2025 Feb;
95(1):34.
PMID: 39955449
Purpose: In 20-30% of the patients, fluoropyrimidines (5-FU) based chemotherapy leads to severe toxicity, which is associated with dihydropyridine dehydrogenase (DPD) deficiency. Therefore, DPYD genotyping became standard practice before treatment...
2.
Bakker M, Hugtenburg J, Bet P, Twisk J, van der Horst H, Slottje P
Br J Gen Pract
. 2025 Jan;
PMID: 39814428
Background: Low-dose amitriptyline and mirtazapine are widely prescribed off-label for insomnia disorder. However, evidence from placebo-controlled studies is lacking. Aim: To assess the effectiveness of low-dose mirtazapine and amitriptyline in...
3.
Brouwer J, Wardenaar K, Nolte I, Liemburg E, Bet P, Snieder H, et al.
BMC Psychiatry
. 2024 May;
24(1):394.
PMID: 38797832
Background: Tailoring antidepressant drugs (AD) to patients' genetic drug-metabolism profile is promising. However, literature regarding associations of ADs' treatment effect and/or side effects with drug metabolizing genes CYP2D6 and CYP2C19...
4.
van Minnen A, Vos L, Bet P, de Jongh A, Linsen F, van Marle H, et al.
Case Rep Psychiatry
. 2024 May;
2024:4768647.
PMID: 38706512
Despite the availability of various treatment approaches for patients with posttraumatic stress disorder (PTSD), some patients do not respond to these therapies, and novel treatment approaches are needed. This study...
5.
van der Veen R, Konigs M, Bakker S, van Iperen A, Peerdeman S, Bet P, et al.
Clin Pharmacol Ther
. 2024 Jan;
115(5):971-987.
PMID: 38294196
Cognitive impairments, common sequelae of acquired brain injury (ABI), significantly affect rehabilitation and quality of life. Currently, there is no solid evidence-base for pharmacotherapy to improve cognitive functioning after ABI,...
6.
de Lange M, Semmler A, Clark T, Mol B, Bet P, Huirne J, et al.
Br J Clin Pharmacol
. 2023 Sep;
90(2):392-405.
PMID: 37653680
Novel gonadotrophin releasing hormone (GnRH) antagonist treatments have recently been developed in combination with hormonal add-back therapy, as an oral treatment option for women suffering from uterine fibroids. Registration trials...
7.
Atmowihardjo L, Schippers J, Duijvelaar E, Bartelink I, Bet P, Swart N, et al.
Crit Care
. 2023 Jun;
27(1):226.
PMID: 37291677
Purpose: A hallmark of acute respiratory distress syndrome (ARDS) is hypoxaemic respiratory failure due to pulmonary vascular hyperpermeability. The tyrosine kinase inhibitor imatinib reversed pulmonary capillary leak in preclinical studies...
8.
Baalbaki N, Duijvelaar E, Said M, Schippers J, Bet P, Twisk J, et al.
Eur J Pharm Sci
. 2023 Mar;
184:106418.
PMID: 36870577
Introduction: In the randomized double-blind placebo-controlled CounterCOVID study, oral imatinib treatment conferred a positive clinical outcome and a signal for reduced mortality in COVID-19 patients. High concentrations of alpha-1 acid...
9.
Henstra M, Feenstra T, Kok R, Spaans H, van Exel E, Dols A, et al.
Front Psychiatry
. 2022 Aug;
13:953686.
PMID: 35911242
Background: Cognitive side-effects are an important reason for the limited use of electroconvulsive therapy (ECT). Cognitive side-effects are heterogeneous and occur frequently in older persons. To date, insight into these...
10.
Rafiq R, Aleva F, Schrumpf J, Daniels J, Bet P, Boersma W, et al.
Am J Clin Nutr
. 2022 Apr;
116(2):491-499.
PMID: 35383823
Background: Vitamin D deficiency is frequently found in patients with chronic obstructive pulmonary disease (COPD). Vitamin D has antimicrobial, anti-inflammatory, and immunomodulatory effects. Therefore, supplementation may prevent COPD exacerbations, particularly...